Try our beta test site

Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1

This study has been completed.
Information provided by (Responsible Party):
ImmunoFrontier, Inc. Identifier:
First received: October 26, 2010
Last updated: March 9, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)